Skip to content

Clinical trials

Phase 3 Mood Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mood Disorders Phase: Phase 3 Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20022
20031
20041
20062
20071
20086
20114
20122
20141
20161
20232
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.5
Takeda5
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.4
Eli Lilly and Company2
GlaxoSmithKline1
Good Samaritan Regional Medical Center, Oregon1
H. Lundbeck A/S1
Pakistan Institute of Living and Learning1
Region Skane1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mood Disorders26
Major Depressive Disorder13
Depressive Disorder12
Mental Disorders9
Bipolar Disorder6
Affective Disorders, Psychotic4
Mania4
Anxiety Disorders3
Generalized Anxiety Disorder3
Psychotic Disorders2

Trials

Showing 26 to 26 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.